We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-4.05%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.11B
AUM Growth
-$170M
Cap. Flow
-$54.7M
Cap. Flow %
-2.59%
Top 10 Hldgs %
25.5%
Holding
2,409
New
42
Increased
215
Reduced
756
Closed
94

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.75M
2
TSLA icon
Tesla
TSLA
+$1.84M
3
CSGP icon
CoStar Group
CSGP
+$1.61M
4
PCG icon
PG&E
PCG
+$1.12M
5
EQT icon
EQT Corp
EQT
+$955K

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Healthcare 13.97%
3 Financials 12.12%
4 Consumer Discretionary 10.21%
5 Industrials 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USLM icon
2176
United States Lime & Minerals
USLM
$3.4B
$14.2K ﹤0.01%
695
FVCB icon
2177
FVCBankcorp
FVCB
$341M
$14.2K ﹤0.01%
926
RMNI icon
2178
Rimini Street
RMNI
$450M
$14.2K ﹤0.01%
3,044
+1,946
+177% +$10.9K
ARLO icon
2179
Arlo Technologies
ARLO
$1.52B
$14.2K ﹤0.01%
3,052
-2,145
-41% -$13.4K
IPSC icon
2180
Century Therapeutics
IPSC
$360M
$14.1K ﹤0.01%
1,426
OOMA icon
2181
Ooma
OOMA
$559M
$14.1K ﹤0.01%
1,143
ORGO icon
2182
Organogenesis Holdings
ORGO
$233M
$14K ﹤0.01%
4,331
+1,800
+71% +$8.13K
IRMD icon
2183
iRadimed
IRMD
$1.12B
$14K ﹤0.01%
465
TDAY
2184
USA Today Co
TDAY
$998M
$14K ﹤0.01%
9,135
+3,745
+69% +$9.09K
BCML icon
2185
BayCom
BCML
$342M
$13.9K ﹤0.01%
793
KRO icon
2186
KRONOS Worldwide
KRO
$981M
$13.9K ﹤0.01%
1,491
KBAL
2187
DELISTED
Kimball International
KBAL
$13.9K ﹤0.01%
2,210
+1,312
+146% +$10.2K
FHTX icon
2188
Foghorn Therapeutics
FHTX
$396M
$13.9K ﹤0.01%
1,620
EYPT icon
2189
EyePoint Inc
EYPT
$1.16B
$13.9K ﹤0.01%
1,753
BCOV
2190
DELISTED
Brightcove, Inc.
BCOV
$13.8K ﹤0.01%
2,198
MAX icon
2191
MediaAlpha
MAX
$798M
$13.8K ﹤0.01%
1,581
FRBA icon
2192
First Bank
FRBA
$471M
$13.7K ﹤0.01%
1,003
IMVT icon
2193
Immunovant
IMVT
$8.7B
$13.7K ﹤0.01%
+2,455
New +$12K
AKYA
2194
DELISTED
Akoya BioSciences
AKYA
$13.7K ﹤0.01%
+1,165
New +$15.3K
STR
2195
DELISTED
Sitio Royalties
STR
$13.7K ﹤0.01%
619
QUOT
2196
DELISTED
Quotient Technology Inc
QUOT
$13.7K ﹤0.01%
5,919
+2,852
+93% +$6.99K
ASPN icon
2197
Aspen Aerogels
ASPN
$508M
$13.6K ﹤0.01%
1,478
ZIMV
2198
DELISTED
ZimVie
ZIMV
$13.6K ﹤0.01%
1,378
ATOM icon
2199
Atomera
ATOM
$219M
$13.6K ﹤0.01%
1,340
UVE icon
2200
Universal Insurance Holdings
UVE
$1.18B
$13.6K ﹤0.01%
1,378

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2022 Portfolio in Review

As of Q3 2022, Metropolitan Life Insurance Company (MetLife) held 2,409 positions worth $2.11B, down 7.5% from $2.28B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2022 filing shows 42 new, 215 increased, 756 reduced and 94 closed positions. Its largest new stake was CoStar Group: 23,153 shares worth $1.61M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $11.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2022 buy was CoStar Group: 23,153 shares worth $1.61M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares MSCI EAFE ETF in Q3 2022, an estimated $3.75M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $11.4M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Healthcare Realty Trust Incorporated in Q3 2022, selling an estimated $433K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $2.11B portfolio in Q3 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 42 new positions and closed 94 in Q3 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 7.5% quarter-over-quarter to $2.11B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.